Evidence map›Paper›PMID 40761283›Full record

ArticleFrontiers in microbiology2025

Enhancing the antibacterial ability of

Hetian Zhou, Yunping Du, Guolian Yu, Wei Liu, Juanjuan Zeng, Bin Wang, Maojin Chen, Yujue Wang, Wenbo Zhang, Xiaona Wei

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Hetian Zhou *School of Life Sciences, Zhengzhou University, Zhengzhou, China.
Yunping Du *Wen's Group Academy, Wens Foodstuff Group Co., Ltd., Xinxing, China.
Guolian YuWen's Group Academy, Wens Foodstuff Group Co., Ltd., Xinxing, China.
Wei LiuWen's Group Academy, Wens Foodstuff Group Co., Ltd., Xinxing, China.
Juanjuan ZengWen's Group Academy, Wens Foodstuff Group Co., Ltd., Xinxing, China.
Bin WangSchool of Life Sciences, Zhengzhou University, Zhengzhou, China.
Maojin ChenWen's Group Academy, Wens Foodstuff Group Co., Ltd., Xinxing, China.
Yujue WangSchool of Life Sciences, Zhengzhou University, Zhengzhou, China.
Wenbo ZhangCollege of Animal Science and Technology, Jiangxi AgriculturalUniversity, Nanchang, China.
Xiaona WeiSchool of Life Sciences, Zhengzhou University, Zhengzhou, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: Methods: In this study, we employed atmospheric and room temperature plasma (ARTP) mutagenesis to improve the antibacterial activity of the isolated D428 strain. Following ARTP mutagenesis and positively screened for its antibacterial ability, the mutant strain 30s-37 was obtained. By comparing the effects of the parental (D428) and mutant (30s-37) strains on broiler growth performance and intestinal microbiota, their probiotic properties performance was evaluated. Results: The results indicated that the use of Discussion: These findings underscore mutagenesis breeding as an effective strategy for probiotic strain optimization, justifying its expanded application in future strain development programs.

Indexed as

antibacterial abilityARTP mutagenesisLigilactobacillus salivariusprobiotic properties characteristicsscreen strains

Identifiers

PMID40761283
PMCPMC12318943

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.